This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2013 Jun;10(6):305.

doi: 10.1038/nrclinonc.2013.69. Epub 2013 Apr 23.

Haematological cancer: new standard of care?

PMID: 23609317
DOI: 10.1038/nrclinonc.2013.69

Comment

Haematological cancer: new standard of care?

Rebecca Kirk. Nat Rev Clin Oncol. 2013 Jun.

. 2013 Jun;10(6):305.

doi: 10.1038/nrclinonc.2013.69. Epub 2013 Apr 23.

Author

PMID: 23609317
DOI: 10.1038/nrclinonc.2013.69

No abstract available

PubMed Disclaimer

Comment on

Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma.
Dunleavy K, Pittaluga S, Maeda LS, Advani R, Chen CC, Hessler J, Steinberg SM, Grant C, Wright G, Varma G, Staudt LM, Jaffe ES, Wilson WH. Dunleavy K, et al. N Engl J Med. 2013 Apr 11;368(15):1408-16. doi: 10.1056/NEJMoa1214561. N Engl J Med. 2013. PMID: 23574119 Free PMC article. Clinical Trial.

References

1. N Engl J Med. 2013 Apr 11;368(15):1408-16 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations